The content of this website is intended for United States audiences only.
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel
The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel, that is otherwise out of specification for commercial release.
View MoreAge
18 Years +
Sex
ALL
Healthy Volunteers
No
Medical Condition
Large B-cell Lymphoma, Follicular Lymphoma
Gender
N/A
Date
Study Type
EXPANDED_ACCESS
Study Phase
Product
Axicabtagene Ciloleucel
Birmingham, Alabama, United States, 35233
Gilbert, Arizona, United States, 85234
Duarte, California, United States, 91010
Denver, Colorado, United States, 80218
Jacksonville, Florida, United States, 32224
Atlanta, Georgia, United States, 30322
Atlanta, Georgia, United States, 30342
Boise, Idaho, United States, 83712
Chicago, Illinois, United States, 60611
Westwood, Kansas, United States, 66205
Baltimore, Maryland, United States, 21201
Boston, Massachusetts, United States, 02114
Boston, Massachusetts, United States, 02215
Boston, Massachusetts, United States, 02215
Ann Arbor, Michigan, United States, 48109
Rochester, Minnesota, United States, 55902
Saint Louis, Missouri, United States, 63110
Omaha, Nebraska, United States, 68198
Hackensack, New Jersey, United States, 07601
Bronx, New York, United States, 10467
Buffalo, New York, United States, 14263
New York, New York, United States, 10021
New York, New York, United States, 10029
Chapel Hill, North Carolina, United States, 27514
Cleveland, Ohio, United States, 44195
Columbus, Ohio, United States, 43201
Portland, Oregon, United States, 97239
Philadelphia, Pennsylvania, United States, 19104
Philadelphia, Pennsylvania, United States, 19111
Pittsburgh, Pennsylvania, United States, 15232
Sioux Falls, South Dakota, United States, 57105
Nashville, Tennessee, United States, 37203
Nashville, Tennessee, United States, 37232
Dallas, Texas, United States, 75246
Houston, Texas, United States, 77030
Houston, Texas, United States, 77030
San Antonio, Texas, United States, 782229
Salt Lake City, Utah, United States, 84112
Richmond, Virginia, United States, 23298
Seattle, Washington, United States, 98109
Morgantown, West Virginia, United States, 26506
Milwaukee, Wisconsin, United States, 53226
Aichi, Japan, 460-0001
Akita, Japan, 010-8543
Bunkyo-ku, Japan, 113-8519
Chiba, Japan, 260-8677
Chuo-ku, Japan, 951-8520
Ehime, Japan, 791-0295
Fukuokaken, Japan, 810-0072
Fukuoka, Japan, 810-8563
Fukuoka, Japan, 812-8582
Fukuoka, Japan, 830-0011
Gifu, Japan, 500-8513
Gunma, Japan, 371-8511
Higashiyama-ku, Japan, 605-0981
Hiroshima, Japan, 730-8619
Hiroshima, Japan, 734-8551
Hyogo, Japan, 650-0017
Hyogo, Japan, 650-0047
Hyogo, Japan, 663-8501
Ibaraki, Japan, 305-8576
Itabashi-Ku, Japan, 173-8606
Kagawa, Japan, 761-0793
Kagoshimaken, Japan, 890-0075
Kanazawa, Japan, 920-8641
Kokurakita-ku, Japan, 802-8555
Kumamoto, Japan, 860-8556
Kyoto, Japan, 602-8566,
Kyoto, Japan, 606-8507
Mie, Japan, 514-8507
Miyagi, Japan, 980-8574
Miyazaki City, Japan, 889-1692
Nagakute, Japan, 480-1195
Nagano, Japan, 390-8621
Nagasaki, Japan, 852-8501
Nagoya, Japan, 4538511
Nagoya, Japan, 466-8560
Nakagami-gun, Japan, 903-0125
Oita, Japan, 879-5593
Okayama, Japan, 700-8558
Okayama, Japan, 7108602
Osaka-shi, Japan, 543-8555
Osaka, Japan, 541-8567
Osaka, Japan, 565-0871
Osaka, Japan, 573-1191
Osaka, Japan, 589-8511
Saitama, Japan, 330-8503
Sapporo Hokkaido, Japan, 060-8648
Shiga, Japan, 520-2192
Shimane, Japan, 693-8501
Shizuoka, Japan, 431-3192
Tochigi, Japan, 329-0498
Tokyo, Japan, 104-0045
Tokyo, Japan, 105-8470
Tokyo, Japan, 105-8471
Tokyo, Japan, 113-8431
Tokyo, Japan, 113-8655
Tokyo, Japan, 113-8677
Tokyo, Japan, 160-8582
Tokyo, Japan, 173-8610
Ube City, Japan, 755-8505
Wakayama, Japan, 641-8510
Yamagata, Japan, 990-9585
Yokohama, Japan, 232-0024
Yokohama, Japan, 236-0004
Yonago-shi, Japan, 683-8504
Share Trial